Citius Pharmaceuticals, Inc. (CTXR)
Market Closed
17 Jul, 20:00
NASDAQ (CM) NASDAQ (CM) Primary 
XMUN $
0. 50
-0.01
-2.9354%
$
6.51M Market Cap
- P/E Ratio
- Div Yield
285,400 Volume
0.03 Eps
$ 0.51
Previous Close 
Want to track CTXR and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | 0.11 | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | 0.13 | - |
| | | - | - |
CTXR Earnings Reports FAQ
What is the earnings per share (EPS) for CTXR?
The current EPS is 0.03.
What is the company's earnings growth rate?
Citius Pharmaceuticals, Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Citius Pharmaceuticals, Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Citius Pharmaceuticals, Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for CTXR at this time, as Citius Pharmaceuticals, Inc has no recent EPS data to calculate it.
